Bolt Biotherapeutics (BOLT)
(Delayed Data from NSDQ)
$0.60 USD
-0.03 (-4.38%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $0.61 +0.01 (2.07%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Bolt Biotherapeutics, Inc. (BOLT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$1.58 | $2.00 | $1.25 | 150.79% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Bolt Biotherapeutics, Inc. comes to $1.58. The forecasts range from a low of $1.25 to a high of $2.00. The average price target represents an increase of 150.79% from the last closing price of $0.63.
Analyst Price Targets (3 )
Broker Rating
Bolt Biotherapeutics, Inc. currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 3.00 a month ago based on five recommendations.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/15/2024 | H.C. Wainwright & Co. | Edward White | Hold | Hold |
5/15/2024 | Guggenheim Securities | Michael Schmidt | Not Available | Hold |
5/15/2024 | Not Identified | Not Identified | Hold | Hold |
5/14/2024 | SVB Securities | Daina M Graybosch | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.00 |
ABR (Last week) | 3.00 |
# of Recs in ABR | 5 |
Average Target Price | $1.58 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 80 of 253 |
Current Quarter EPS Est: | -0.43 |
BOLT FAQs
Bolt Biotherapeutics, Inc. (BOLT) currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for Bolt Biotherapeutics, Inc. (BOLT) is $1.58. The current on short-term price targets is based on 4 reports.
The forecasts for Bolt Biotherapeutics, Inc. (BOLT) range from a low of $1.25 to a high of $2. The average price target represents a increase of $163.33 from the last closing price of $.60.
The current UPSIDE for Bolt Biotherapeutics, Inc. (BOLT) is 163.33%
Based on short-term price targets offered by three analysts, the average price target for Bolt Biotherapeutics, Inc. comes to $1.58. The forecasts range from a low of $1.25 to a high of $2.00. The average price target represents an increase of 150.79% from the last closing price of $0.63.